Albert Bourla, CEO of Pfizer Inc., tested positive for COVID-19. He tweeted on Monday that he received four shots of the COVID-19 vaccine developed by his company in collaboration with BioNTech SE. Pfizer CEO said that he is “experiencing very mild symptoms,” and that he has begun taking Paxlovid, Pfizer’s COVID-19 antiviral.
Press Release
NEW YORK, AUGUST 15, 2022 – Pfizer Inc. (NYSE: PFE) – I would like to inform the public that I have tested positive for COVID-19. I am grateful to have received four doses of the Pfizer-BioNTech vaccine and I am feeling well while experiencing very mild symptoms. I have started a course of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), I am isolating in place as well as following all public health precautions.
We have come so far in the past two years in our efforts to battle this disease that I am confident that I will have a speedy recovery. I am incredibly grateful for the tireless efforts of my Pfizer colleagues who worked to make vaccines and treatments available for me and people around the world
